Industry Information | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives

Hello! Welcome to Huateng Pharma

Hotline：+86 0731-89916275 sales@huatengusa.com

中文 / English

Batch Search Chem structure Search

High-end suppliers of chemical, biological reagents, pharmaceutical intermediates and APIs

Quick Links >> Chemical Products Biological Reagent PEG Derivatives Featured Intermediates

Current Location：Home > Industry Information

Industry Information

EZH2 inhibitor Combined With PD-1 inhibitor, Enhance The Therapeutic Effect of Prostate Cancer
by Journalist Huateng
Prostate cancer is cancer that occurs in the prostate. It is the most common cancer among men (after skin cancer). Unfortunately, metastatic castration-resistant prostate cancer (mCRPC) is still incurable.
Top 10 Oncology Pharmaceutical Companies 2020
by Journalist Huateng
The top ten pharmaceutical companies based on global oncology revenue in 2020.
Application of Lipid Nanoparticles in COVID-19 mRNA Vaccines
by Journalist Huateng
The use of lipid nanoparticles (LNPs) in BioNTech/Pfizer and Moderna COVID-19 mRNA vaccines.
What is the Difference Between API and Intermediate?
by Journalist Huateng
What is Favipiravir? How Does It Work for COVID-19?
by Journalist Huateng
We introduce here what is Favipiravir, Mechanisms of Action of Favipiravir, Clinical Evidence of Favipiravir to COVID-19,
Brilacidin, A Candidate Drug For The Treatment of COVID-19
by Journalist Huateng
The Brilacidin trial for the treatment of COVID-19 infection has started in February 2021 and is expected to be completed in July 2021.
Development and Overview of Anti-influenza Drugs
by Journalist Huateng
There are several approved influenza antiviral drugs, including Relenza (zanamivir), Tamiflu (oseltamivir phosphate), Inavir (Laninamivir octanoate), Rapivab (peramivir), Xofluza (baloxavir marboxil) nad more.
Baloxavir Marboxil for Uncomplicated Influenza: Mechanism of Action & Side Effects
by Journalist Huateng
Baloxavir marboxil, marketed as Xofluza, is a first-in-class, one-dose oral agent first approved by the FDA in 2018 for the treatment of acute, uncomplicated influenza in individuals 12 years and older, who have been symptomatic for less than 24 hours.
Antidiabetic Drugs Classification and Mechanism of Action
by Journalist Huateng
This article gives you information about antidiabetic drugs classification and their mechanism of action.
Two Major Factors And Prevention Methods For Gastric Cancer
by Journalist Huateng
China is the country with the largest number of incidences and deaths from gastric cancer in the world. According to the latest global cancer data released by the World Health Organization International Agency for Research on Cancer (WHO IARC) in 2020, there are 1.089 million new cases of gastric cancer worldwide and 0.768 million deaths in 2020. There are 478,000 new cases of gastric cancer (43.9%) and 373,000 deaths from gastric cancer (48.5%) in China.
New Mechanism of Metformin For Controlling Lipogenesis And Inhibiting The Growth of Cancer Cells
by Journalist Huateng
On March 1, 2021, the team of Xiaoping Yang from Hunan Normal University published an online research paper titled: Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c/FASN axis in the Journal of Signal Transduction and Targeted Therapy.
Nature: Leprosy Drug Clofazimine Effectively Inhibits Coronaviruses
by Journalist Huateng
On March 16, 2021, Kwok-Yung Yuen and his team from the University of Hong Kong published a research paper in Nature titled Clofazimine broadly inhibits coronaviruses including SARS-CoV-2.

Links

FAQs

Copyright © 2013-2020 Hunan HuaTeng Pharmaceutical Co., Ltd. All right reserved Tel: +86 0731 89916275, +1 857-928-2050 E-mail: sales@huatengusa.com

Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, P.R. China. ZIP Code: 410006

Tel

+86 0731 89916275
Email
sales@huatengusa.com
To Top